Unlock stock picks and a broker-level newsfeed that powers Wall Street.

3 ASX Penny Stocks With Market Caps Under A$500M

In This Article:

The Australian stock market recently demonstrated resilience, with the ASX climbing above the 7,800 points level despite mixed performances in global markets. In such a landscape, investors often seek out smaller or newer companies that can offer unique growth opportunities. Although "penny stocks" may sound like an outdated term, these stocks represent potential value investments; when backed by strong financials and fundamentals, they can provide significant upside potential.

Top 10 Penny Stocks In Australia

Name

Share Price

Market Cap

Financial Health Rating

CTI Logistics (ASX:CLX)

A$1.57

A$122.48M

★★★★☆☆

MotorCycle Holdings (ASX:MTO)

A$2.10

A$154.99M

★★★★★★

EZZ Life Science Holdings (ASX:EZZ)

A$1.58

A$74.53M

★★★★★★

IVE Group (ASX:IGL)

A$2.35

A$362.33M

★★★★★☆

GTN (ASX:GTN)

A$0.60

A$115.38M

★★★★★★

Bisalloy Steel Group (ASX:BIS)

A$3.19

A$151.37M

★★★★★★

Regal Partners (ASX:RPL)

A$1.795

A$603.41M

★★★★★★

Sugar Terminals (NSX:SUG)

A$1.10

A$363.6M

★★★★★★

NRW Holdings (ASX:NWH)

A$2.47

A$1.13B

★★★★★☆

LaserBond (ASX:LBL)

A$0.3825

A$44.88M

★★★★★★

Click here to see the full list of 982 stocks from our ASX Penny Stocks screener.

Underneath we present a selection of stocks filtered out by our screen.

Dimerix

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Dimerix Limited is a biopharmaceutical company based in Australia that focuses on developing and commercializing pharmaceutical products to address unmet medical needs, with a market cap of A$237.68 million.

Operations: Dimerix generates revenue primarily from its biotechnology segment, amounting to A$0.74 million.

Market Cap: A$237.68M

Dimerix Limited, with a market cap of A$237.68 million, is pre-revenue, generating only A$0.74 million in revenue from its biotechnology segment. The company reported a net loss of A$12.91 million for the half-year ending December 2024, an increase from the prior year. Despite being debt-free and having experienced management and board members, Dimerix faces challenges with less than a year of cash runway if current cash flow trends persist. Its addition to the S&P/ASX All Ordinaries Index reflects some market recognition despite its financial hurdles and high volatility stability over the past year.

ASX:DXB Financial Position Analysis as at Apr 2025
ASX:DXB Financial Position Analysis as at Apr 2025

Sovereign Metals

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Sovereign Metals Limited, with a market cap of A$425.91 million, is involved in the exploration and development of mineral resource projects in Malawi.